NEWS
Prolira exhibits @ nursing festival
Staff from all Dutch hospitals that participate in CLEO (Clinical Evaluation of DeltaScan) gathered on 5 November 2019 @ UMC Utrecht, to practise using DeltaScan, in preparation of the start of the intervention period of CLEO, in which DeltaScan will be used to daily detect and monitor delirium in their patients.
Superuser day @ UMC Utrecht & Prolira for CLEO
Staff from all Dutch hospitals that participate in CLEO (Clinical Evaluation of DeltaScan) gathered on 5 November 2019 @ UMC Utrecht, to practise using DeltaScan, in preparation of the start of the intervention period of CLEO, in which DeltaScan will be used to daily detect and monitor delirium in their patients.
DeltaScan presented at ADS congress, Boston USA -June 2019
The American Delirium Society’s (ADS) congress took place in Boston, USA on 17 and 18 June 2019.
Prolira presented DeltaScan to the nearly 300 delirium researchers and clinicians from North and South America, Australia and Europe.
DeltaScan presented at EDA congress, November 2018
The European Delirium Association’s (EDA) congress took place in Utrecht, the Netherlands on 1 and 2 November 2018.
Prolira presented DeltaScan to the approximately 250 delirium researchers from over 15 countries who attended and contributed to the congress.
Prolira’s DeltaScan was presented to all attendees.
DeltaScan project gains EU Horizon 2020 grant
Prolira’s DeltaScan project has received funding from the European Union’s Horizon 2020 research and innovation programme!
Click on the picture to read more.
14 March 2018 is World Delirium Awareness Day / Wereld Delirium Dag
14 March 2018 is World Delirium Awareness Day (WDAD).
And in the battle to beat delirium, Prolira delivers the first DeltaScan Patches @ UMC Utrecht!
Why do we need WDAD? Click on the picture to read why.
DeltaScan on the Dutch National News
Click on the picture to watch the item of the National 8 o’clock News in the Netherlands (subtitled in English) on 7 March 2018.
University Medical Center Utrecht and company Prolira BV of the Netherlands have developed an innovative device to detect delirium. This mobile monitor, the Deltascan, measures within one minute whether a patient has a delirium. With a delirium, patients suddenly suffer from serious confusion due to a physical cause, such as an infection. One in eight hospital patients, especially the elderly and Intensive Care patients, will experience this.
DeltaScan in UMC Utrecht is the first medical device that shows the probability of delirium.
Prolira B.V.
Padualaan 8
3584 CH Utrecht
The Netherlands
tel: +31 (0)6 2297 8972
info@prolira.com